$BRQL
brooqLy, Inc.

2023 Q3 Form 10-Q Financial Statement

#000147793223006022 Filed on August 14, 2023

View on sec.gov

Income Statement

Concept 2023 Q3 2023 Q2
Revenue $1.00 $1.00
YoY Change -99.5% -99.85%
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin $77.54K $34.65K
YoY Change
% of Gross Profit
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $7.960K $7.480K
YoY Change
% of Gross Profit
Operating Expenses $77.54K $34.65K
YoY Change -45.62% -30.12%
Operating Profit -$77.54K -$34.65K
YoY Change -45.55% -29.18%
Interest Expense $31.86K $0.00
YoY Change
% of Operating Profit
Other Income/Expense, Net $270.00 $0.00
YoY Change 462.5%
Pretax Income -$109.1K -$34.65K
YoY Change -23.33% -29.18%
Income Tax $0.00 $0.00
% Of Pretax Income
Net Earnings -$109.1K -$34.65K
YoY Change -23.33% -29.18%
Net Earnings / Revenue -10913500.0% -3465100.0%
Basic Earnings Per Share
Diluted Earnings Per Share $0.00 $0.00
COMMON SHARES
Basic Shares Outstanding 23.63M shares 23.58M shares
Diluted Shares Outstanding 23.89M shares

Balance Sheet

Concept 2023 Q3 2023 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments $3.130K $6.430K
YoY Change
Cash & Equivalents $3.131K $6.426K
Short-Term Investments
Other Short-Term Assets $30.20K $30.20K
YoY Change
Inventory
Prepaid Expenses $30.20K $30.20K
Receivables
Other Receivables
Total Short-Term Assets $33.34K $36.63K
YoY Change 2075.91%
LONG-TERM ASSETS
Property, Plant & Equipment
YoY Change
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets
YoY Change
Total Long-Term Assets $128.7K $114.6K
YoY Change -7.41%
TOTAL ASSETS
Total Short-Term Assets $33.34K $36.63K
Total Long-Term Assets $128.7K $114.6K
Total Assets $162.0K $151.2K
YoY Change 15.31%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $66.14K $53.61K
YoY Change 2.07%
Accrued Expenses $25.35K
YoY Change
Deferred Revenue
YoY Change
Short-Term Debt $55.00K $55.00K
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $169.3K $131.4K
YoY Change 72.78%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00
YoY Change
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities $0.00 $0.00
YoY Change
TOTAL LIABILITIES
Total Short-Term Liabilities $169.3K $131.4K
Total Long-Term Liabilities $0.00 $0.00
Total Liabilities $169.3K $131.4K
YoY Change
SHAREHOLDERS EQUITY
Retained Earnings -$759.1K -$650.0K
YoY Change 38.7% 60.5%
Common Stock $2.424K $2.364K
YoY Change 8.6%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity -$7.295K $19.84K
YoY Change
Total Liabilities & Shareholders Equity $162.0K $151.2K
YoY Change 15.31% 96.67%

Cashflow Statement

Concept 2023 Q3 2023 Q2
OPERATING ACTIVITIES
Net Income -$109.1K -$34.65K
YoY Change -23.33% -29.18%
Depreciation, Depletion And Amortization $7.960K $7.480K
YoY Change
Cash From Operating Activities $18.71K -$102.5K
YoY Change
INVESTING ACTIVITIES
Capital Expenditures $22.00K $0.00
YoY Change
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities -$22.00K $0.00
YoY Change
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 0.000 75.00K
YoY Change
NET CHANGE
Cash From Operating Activities 18.71K -102.5K
Cash From Investing Activities -22.00K 0.000
Cash From Financing Activities 0.000 75.00K
Net Change In Cash -3.290K -27.55K
YoY Change
FREE CASH FLOW
Cash From Operating Activities $18.71K -$102.5K
Capital Expenditures $22.00K $0.00
Free Cash Flow -$3.290K -$102.5K
YoY Change

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2022Q2 us-gaap Net Income Loss
NetIncomeLoss
-48926 usd
CY2023Q2 brooqly Shares Issued For Cash Amount
SharesIssuedForCashAmount
20000 usd
CY2023Q2 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
114619 usd
CY2022Q4 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
129488 usd
CY2023Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 usd
CY2022Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 usd
CY2023Q2 us-gaap Operating Expenses
OperatingExpenses
34652 usd
CY2022Q2 us-gaap Operating Expenses
OperatingExpenses
49587 usd
CY2023Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-34651 usd
CY2022Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-48927 usd
CY2023Q2 us-gaap Other Income
OtherIncome
0 usd
CY2023Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-34651 usd
CY2022Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-48926 usd
us-gaap Depreciation And Amortization
DepreciationAndAmortization
1131 usd
us-gaap Issuance Of Stock And Warrants For Services Or Claims
IssuanceOfStockAndWarrantsForServicesOrClaims
100000 usd
us-gaap Issuance Of Stock And Warrants For Services Or Claims
IssuanceOfStockAndWarrantsForServicesOrClaims
0 usd
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-64855 usd
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
21839 usd
us-gaap Increase Decrease In Due To Related Parties
IncreaseDecreaseInDueToRelatedParties
898 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-148575 usd
us-gaap Payments To Acquire Software
PaymentsToAcquireSoftware
0 usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
0 usd
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
100000 usd
CY2023Q2 us-gaap Stockholders Equity
StockholdersEquity
19840 usd
dei Entity Central Index Key
EntityCentralIndexKey
0001854526
dei Amendment Flag
AmendmentFlag
false
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q2
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2023
CY2022Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2022Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
200000000 shares
CY2022Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
22584982 shares
CY2023Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
23634982 shares
brooqly Cancellation Of Shares
CancellationOfShares
120000 shares
dei Document Type
DocumentType
10-Q
dei Document Quarterly Report
DocumentQuarterlyReport
true
dei Document Period End Date
DocumentPeriodEndDate
2023-06-30
dei Document Transition Report
DocumentTransitionReport
false
dei Entity File Number
EntityFileNumber
000-56399
dei Entity Registrant Name
EntityRegistrantName
brooqLy, Inc.
dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
NV
dei Entity Tax Identification Number
EntityTaxIdentificationNumber
86-2265420
dei Entity Address Address Line1
EntityAddressAddressLine1
10101 S. Roberts Road
dei Entity Address Address Line2
EntityAddressAddressLine2
Suite 209
dei Entity Address City Or Town
EntityAddressCityOrTown
Palos Hill
dei Entity Address State Or Province
EntityAddressStateOrProvince
IL
dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
60465
dei City Area Code
CityAreaCode
718
dei Local Phone Number
LocalPhoneNumber
513-7776
dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
dei Entity Small Business
EntitySmallBusiness
true
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
true
dei Entity Ex Transition Period
EntityExTransitionPeriod
false
dei Entity Shell Company
EntityShellCompany
false
CY2023Q3 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
23634982 shares
CY2023Q2 us-gaap Notes Payable
NotesPayable
30000 usd
CY2023Q2 us-gaap Liabilities Subject To Compromise
LiabilitiesSubjectToCompromise
25000 usd
CY2022Q4 us-gaap Liabilities Subject To Compromise
LiabilitiesSubjectToCompromise
0 usd
CY2023Q2 brooqly Due To Related Party Current
DueToRelatedPartyCurrent
22804 usd
CY2022Q4 brooqly Due To Related Party Current
DueToRelatedPartyCurrent
21906 usd
CY2023Q2 us-gaap Liabilities Current
LiabilitiesCurrent
131409 usd
CY2023Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2023Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
200000000 shares
CY2022Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
22584982 shares
CY2023Q2 us-gaap Common Stock Value
CommonStockValue
2364 usd
CY2023Q2 brooqly Common Stock To Be Issued
CommonStockToBeIssued
0 usd
CY2022Q4 brooqly Common Stock To Be Issued
CommonStockToBeIssued
20000 usd
CY2022Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-480469 usd
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
-10672 usd
CY2022Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
129693 usd
us-gaap Revenues
Revenues
776 usd
us-gaap Professional Fees
ProfessionalFees
66506 usd
CY2022Q2 us-gaap Other General And Administrative Expense
OtherGeneralAndAdministrativeExpense
30095 usd
us-gaap Other General And Administrative Expense
OtherGeneralAndAdministrativeExpense
127488 usd
us-gaap Operating Expenses
OperatingExpenses
169490 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
-169488 usd
us-gaap Other Income
OtherIncome
1 usd
CY2023Q2 us-gaap Interest And Debt Expense
InterestAndDebtExpense
0 usd
CY2022Q2 us-gaap Interest And Debt Expense
InterestAndDebtExpense
0 usd
us-gaap Interest And Debt Expense
InterestAndDebtExpense
0 usd
us-gaap Interest And Debt Expense
InterestAndDebtExpense
0 usd
CY2023Q2 us-gaap Other Operating Income Expense Net
OtherOperatingIncomeExpenseNet
0 usd
CY2022Q2 us-gaap Other Operating Income Expense Net
OtherOperatingIncomeExpenseNet
0 usd
us-gaap Other Operating Income Expense Net
OtherOperatingIncomeExpenseNet
1 usd
us-gaap Other Operating Income Expense Net
OtherOperatingIncomeExpenseNet
0 usd
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-169487 usd
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-115638 usd
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 usd
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 usd
CY2023Q2 us-gaap Net Income Loss
NetIncomeLoss
-34651 usd
us-gaap Net Income Loss
NetIncomeLoss
-169487 usd
us-gaap Net Income Loss
NetIncomeLoss
-115638 usd
CY2023Q2 brooqly Earnings Per Shares Basic And Diluted
EarningsPerSharesBasicAndDiluted
-0.00
CY2022Q2 brooqly Earnings Per Shares Basic And Diluted
EarningsPerSharesBasicAndDiluted
-0.00
brooqly Earnings Per Shares Basic And Diluted
EarningsPerSharesBasicAndDiluted
-0.01
brooqly Earnings Per Shares Basic And Diluted
EarningsPerSharesBasicAndDiluted
-0.01
CY2023Q2 brooqly Weighted Average Number Of Share Outstanding Basics And Diluted
WeightedAverageNumberOfShareOutstandingBasicsAndDiluted
23620422 shares
CY2022Q2 brooqly Weighted Average Number Of Share Outstanding Basics And Diluted
WeightedAverageNumberOfShareOutstandingBasicsAndDiluted
22019652 shares
brooqly Weighted Average Number Of Share Outstanding Basics And Diluted
WeightedAverageNumberOfShareOutstandingBasicsAndDiluted
23174070 shares
brooqly Weighted Average Number Of Share Outstanding Basics And Diluted
WeightedAverageNumberOfShareOutstandingBasicsAndDiluted
22121612 shares
us-gaap Net Income Loss
NetIncomeLoss
-169487 usd
us-gaap Net Income Loss
NetIncomeLoss
-115638 usd
us-gaap Depreciation And Amortization
DepreciationAndAmortization
14869 usd
us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
30000 usd
us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
0 usd
us-gaap Increase Decrease In Due To Related Parties
IncreaseDecreaseInDueToRelatedParties
23204 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-69463 usd
us-gaap Payments To Acquire Software
PaymentsToAcquireSoftware
23028 usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-23028 usd
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
68000 usd
us-gaap Proceeds From Notes Payable
ProceedsFromNotesPayable
30000 usd
us-gaap Proceeds From Notes Payable
ProceedsFromNotesPayable
0 usd
us-gaap Proceeds From Issuance Of Secured Debt
ProceedsFromIssuanceOfSecuredDebt
25000 usd
us-gaap Proceeds From Issuance Of Secured Debt
ProceedsFromIssuanceOfSecuredDebt
0 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
155000 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
68000 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
6425 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
-24492 usd
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
1 usd
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
30035 usd
CY2023Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
6426 usd
CY2022Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
5543 usd
us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
0 usd
us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
0 usd
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
-10672 usd
CY2023Q1 brooqly Shares Issued For Cash Amount
SharesIssuedForCashAmount
80000 usd
CY2023Q1 brooqly Shares Issued For Services Amount
SharesIssuedForServicesAmount
100000 usd
CY2023Q1 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-134836 usd
CY2023Q2 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-34651 usd
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
57688 usd
CY2022Q1 brooqly Shares Issued For Cash Amount
SharesIssuedForCashAmount
13000 usd
CY2022Q1 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-66712 usd
CY2022Q1 us-gaap Stockholders Equity
StockholdersEquity
3975 usd
CY2022Q2 brooqly Shares Issued For Cash Amount
SharesIssuedForCashAmount
55000 usd
CY2022Q2 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-48926 usd
CY2022Q2 us-gaap Stockholders Equity
StockholdersEquity
10051 usd
us-gaap Use Of Estimates
UseOfEstimates
<p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">The preparation of financial statements in conformity with generally accepted accounting principles requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, revenue and expenses and disclosure of contingent assets and liabilities at the date the financial statements and the reported amount of revenues and expenses during the reporting period. Actual results could differ from those estimates.</p>
CY2023Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
200000000 shares
CY2023Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2023Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
23634982 shares
CY2022 us-gaap Conversion Of Stock Shares Issued1
ConversionOfStockSharesIssued1
550000 shares
CY2022 us-gaap Proceeds From Issuance Of Preferred Stock And Preference Stock
ProceedsFromIssuanceOfPreferredStockAndPreferenceStock
78000 usd
CY2022 brooqly Shares Issued For Services Amount
SharesIssuedForServicesAmount
144800 usd
CY2022 us-gaap Stock Issued During Period Shares Issued For Services
StockIssuedDuringPeriodSharesIssuedForServices
550000 shares
CY2022 us-gaap Stock Issued During Period Value Issued For Services
StockIssuedDuringPeriodValueIssuedForServices
78000 usd
CY2022 us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
350000 shares
CY2022 us-gaap Proceeds From Warrant Exercises
ProceedsFromWarrantExercises
35000 usd
brooqly Shares Issued For Services Amount
SharesIssuedForServicesAmount
20000 usd
us-gaap Proceeds From Issuance Of Preferred Stock And Preference Stock
ProceedsFromIssuanceOfPreferredStockAndPreferenceStock
100000 usd
CY2022 brooqly Shares To Be Issued Shares
SharesToBeIssuedShares
617482 shares
us-gaap Stock Issued During Period Shares Issued For Services
StockIssuedDuringPeriodSharesIssuedForServices
550000 shares
brooqly Purchase Of Shares During Period
PurchaseOfSharesDuringPeriod
20000 shares
us-gaap Conversion Of Stock Shares Issued1
ConversionOfStockSharesIssued1
500000 shares
CY2023Q1 brooqly Cancellation Of Shares
CancellationOfShares
1000000 shares
CY2023Q1 us-gaap Equity Method Investment Aggregate Cost
EquityMethodInvestmentAggregateCost
75000 usd
CY2023Q1 us-gaap Net Asset Value Per Share
NetAssetValuePerShare
0.20
CY2023Q1 brooqly Desription Of Investment1
DesriptionOfInvestment1
there is an adjusted number of Common Stock Shares (and no warrants) of 125,000 shares, rather than the 1,000,000 shares. The difference of 875,000 shares will be cancelled and returned to the Company’s treasury. resulting in a decrease of the Company’s outstanding shares by 875,000 shares
us-gaap Profit Loss
ProfitLoss
-115638 usd
CY2023Q2 brooqly Operating Gain Loss Carryforwards
OperatingGainLossCarryforwards
-649956 usd
CY2022Q4 brooqly Operating Gain Loss Carryforwards
OperatingGainLossCarryforwards
-480469 usd
CY2022Q4 brooqly Net Operating Loss Carry Forward
NetOperatingLossCarryForward
169488 usd
CY2023Q2 brooqly Net Operating Loss Carry Forward
NetOperatingLossCarryForward
649956 usd
CY2023Q2 us-gaap Capital Units Total Cost To Investors
CapitalUnitsTotalCostToInvestors
5000000 usd

Files In Submission

Name View Source Status
0001477932-23-006022-index-headers.html Edgar Link pending
0001477932-23-006022-index.html Edgar Link pending
0001477932-23-006022.txt Edgar Link pending
0001477932-23-006022-xbrl.zip Edgar Link pending
brooqly-20230630.xsd Edgar Link pending
brooqly_10q.htm Edgar Link pending
brooqly_ex311.htm Edgar Link pending
brooqly_ex312.htm Edgar Link pending
brooqly_ex321.htm Edgar Link pending
brooqly_ex322.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
brooqly-20230630_cal.xml Edgar Link unprocessable
brooqly-20230630_lab.xml Edgar Link unprocessable
brooqly-20230630_def.xml Edgar Link unprocessable
brooqly-20230630_pre.xml Edgar Link unprocessable
FilingSummary.xml Edgar Link unprocessable
brooqly_10q_htm.xml Edgar Link completed